EV Biologics (EV Biologics) Scaled Net Operating Assets : 1.21 (As of Dec. 2017)

View and export this data going back to 2015. Start your Free Trial

What is EV Biologics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

EV Biologics's operating assets for the quarter that ended in Dec. 2017 was $50.57 Mil. EV Biologics's operating liabilities for the quarter that ended in Dec. 2017 was $10.25 Mil. EV Biologics's Total Assets for the quarter that ended in Jun. 2017 was $33.28 Mil. Therefore, EV Biologics's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2017 was 1.21.

EV Biologics Scaled Net Operating Assets Historical Data

The historical data trend for EV Biologics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EV Biologics Scaled Net Operating Assets Chart

EV Biologics Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Scaled Net Operating Assets

0.56

0.48

0.62

0.24

0.34

EV Biologics Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17	Dec17
Scaled Net Operating Assets	Get a 7-Day Free Trial												0.19	0.43	0.36	0.36	1.21

Competitive Comparison of EV Biologics's Scaled Net Operating Assets

For the Biotechnology subindustry, EV Biologics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EV Biologics's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EV Biologics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where EV Biologics's Scaled Net Operating Assets falls into.

EV Biologics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

EV Biologics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2017 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jun. 2017 )
=	(Operating Assets (A: Jun. 2017 )	-	Operating Liabilities (A: Jun. 2017 ))	/	Total Assets (A: Jun. 2016 )
=	(31.464	-	19.212)	/	36.443
=	0.34

where

	Operating Assets		(A: Jun. 2017 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	33.278	-	1.814
=	31.464

	Operating Liabilities		(A: Jun. 2017 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	29.559	-	0	-	10.347
=	19.212

EV Biologics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2017 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2017 )
=	(Operating Assets (Q: Dec. 2017 )	-	Operating Liabilities (Q: Dec. 2017 ))	/	Total Assets (Q: Jun. 2017 )
=	(50.567	-	10.25)	/	33.278
=	1.21

where

	Operating Assets		(Q: Dec. 2017 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	58.954	-	8.387
=	50.567

	Operating Liabilities		(Q: Dec. 2017 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	16.719	-	0	-	6.469
=	10.25

EV Biologics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of EV Biologics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

EV Biologics (EV Biologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EV Biologics Inc (OTCPK:YECO) » Definitions » Scaled Net Operating Assets

Comparable Companies

XCNQ:NIRV ENVB BLCM NLSP BRTX ADTX XKRX:066830 ALLR XMAD:ADL ARTL

Traded in Other Exchanges

N/A

Address

1621 Central Avenue, Cheyenne, WY, USA, 82001

Website

https://www.evbiologics.com

EV Biologics Inc is developing the extraordinary biological properties of extracellular vesicles (EVs) to create the next generation of diagnostic modalities and safe, effective biotherapeutics to improve outcomes of serious clinical conditions, increase natural longevity and transform lives.

Executives

Daniel S Mckinney	director, 10 percent owner, officer: CEO	TWO IFC, 19TH FLOOR, 8 FINANCE STREET, CENTRAL, HONG KONG F4 000000
Michael W Harlan	director	C/O WASTE CONNECTIONS, INC., 610 APPLEWOOD CRESCENT, SUITE 200, VAUGHAN A6 L4K 0C3